Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-06-001298
Filing Date
2006-02-14
Accepted
2006-02-14 14:52:08
Documents
1
Group Members
GLENVIEW CAPITAL GP, LLCGLENVIEW CAPITAL MANAGEMENT, LLCLAWRENCE M. ROBBINS

Document Format Files

Seq Description Document Type Size
1 efc6-0432_formsc13ga.txt SC 13G/A 22764
  Complete submission text file 0000905148-06-001298.txt   24839
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 06613295
SIC: 2834 Pharmaceutical Preparations

Mailing Address 399 PARK AVENUE FLOOR 39 NEW YORK NY 10022
Business Address 399 PARK AVENUE FLOOR 39 NEW YORK NY 10022 2128124700
GLENVIEW CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001138995 (see all company filings)

EIN.: 134136746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A